VERU INC. Finance Lease, Liability, to be Paid, Year One
VERU INC. (VERU) had Finance Lease, Liability, to be Paid, Year One of $9.50 thousand as of 2021-09-30, per its 10-K filed 2021-12-02.
Discontinued › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2021-12-02
- 2021-09-30: Finance Lease, Liability, to be Paid, Year One $9.50K.
- 2020-09-30: Finance Lease, Liability, to be Paid, Year One $22.20K.
| Period end | Finance Lease, Liability, to be Paid, Year One |
|---|---|
| 2021-09-30 | $9.50K 10-K · filed 2021-12-02 |
| 2020-09-30 | $22.20K 10-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |